Royal Bank of Canada »

Lyra Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2025-09-30 $10k 1.3k 7.69
2025-06-30 $8.5k 1.1k 7.69

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding Lyra Therapeutics

Perceptive Advisors
Sabby Management
Vanguard Group
Ikarian Capital
Citadel Advisors
Geode Capital Management
UBS Group
Morgan Stanley
BlackRock
Royal Bank of Canada
Tower Research Capital
FMR
Signature Resources Capital Management
EverSource Wealth Advisors
Jones Financial Companies, L.L

View all funds holding Lyra Therapeutics